BL
JAZZ icon

BFSG LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

BFSG LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Hold
5,939
– – 0.13% 155
2026
Q1 		$1.12M Buy
+5,939
New +$1.04M 0.11% 159
2024
Q1 		– Sell
-3
Closed -$369 – 683
2023
Q4 		$369 Buy
+3
New +$374 ﹤0.01% 589
2020
Q2 		– Sell
-19,845
Closed -$1.98M – 171
2020
Q1 		$1.98M Buy
+19,845
New +$2.57M 0.51% 66

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

BFSG LLC's JAZZ Position: Q2 2026 in Review

BFSG LLC held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 5,939 shares worth $1.43M. The position accounts for 0.13% of the portfolio, ranked #155.

BFSG LLC first reported a position in JAZZ in Q1 2020 and has held it in 4 quarters since. The position peaked at $1.98M in Q1 2020. 645 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • BFSG LLC held 5,939 shares of Jazz Pharmaceuticals worth $1.43M as of Q2 2026.
  • BFSG LLC left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.13% of BFSG LLC's portfolio in Q2 2026, its #155 holding.
  • BFSG LLC first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 4 quarters since.
  • BFSG LLC's Jazz Pharmaceuticals position peaked at $1.98M in Q1 2020.
  • 645 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.